These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 1774958
21. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival. Sagaster V, Ohler L, Berer A, Kabrna E, Ofner P, Lechner K, Geissler K. Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175 [Abstract] [Full Text] [Related]
22. Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia. Kyriakou D, Eliopoulos AG, Alexandrakis M, Kalokyri I, Eliopoulos GD. Haematologia (Budap); 1996 Jan; 28(1):1-7. PubMed ID: 9283897 [Abstract] [Full Text] [Related]
29. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R. Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595 [Abstract] [Full Text] [Related]
31. Proposals for the classification of the myelodysplastic syndromes. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Br J Haematol; 1982 Jun; 51(2):189-99. PubMed ID: 6952920 [Abstract] [Full Text] [Related]
32. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes. Visani G, Tosi P, Finelli C, Gamberi B, Zauli G, Cenacchi A, Fogli M, Colombini R, Tura S. Haematologica; 1992 Jun; 77(2):142-5. PubMed ID: 1383105 [Abstract] [Full Text] [Related]
33. Myelodysplastic syndromes in patients under 50 years old: a single institution experience. Breccia M, Mengarelli A, Mancini M, Biondo F, Gentilini F, Latagliata R, Mandelli F, Alimena G. Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670 [Abstract] [Full Text] [Related]
34. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB). Omine M, Yamauchi H. Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556 [Abstract] [Full Text] [Related]
35. [An analysis of prognostic factors in 80 myelodysplastic syndrome]. Xu XQ, Wang JM, Lu SQ, Chen L, Yang JM, Zhang WP, Song XM, Xu YQ, Gong SL, Hou J, Ni X. Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):723-7. PubMed ID: 19176004 [Abstract] [Full Text] [Related]
37. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes]. García Marco J, Miguel Sosa A, García Conde J, Miguel García A, Arbona C, Escrig V, Benet I, Navarro I, Ruiz A, Carbonell F. Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051 [Abstract] [Full Text] [Related]
39. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Maze R, Horie M, Hendrie P, Vadhan-Raj S, Tricot G, Gordon M, Nemunaitis J, Ashman LK, Broxmeyer HE. Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784 [Abstract] [Full Text] [Related]
40. [Prognostic factors in myelodysplastic syndromes: analysis of 72 cases]. Krieger O, Bernhart M, Desser H, Nowotny H, Lutz D. Wien Klin Wochenschr; 1985 Feb 01; 97(3):131-6. PubMed ID: 3984346 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]